SCHEMBL7937708

SCHEMBL7937708

COc1ccc2c(Oc3ccc(N)cc3)c(-c3cccc(Cl)c3)ccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.45
CYP3A4 P08684 2/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2E1 P05181 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP4B1 P13584 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP3A5 P20815 1/20 0.39
CYP2A7 P20853 1/20 0.39
CYP3A7 P24462 1/20 0.39
CYP2F1 P24903 1/20 0.39
CYP2C18 P33260 1/20 0.39
CYP2C19 P33261 1/20 0.39
CYP2J2 P51589 1/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4F8 P98187 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7940249 0.90 SMN1; SMN2 (0.52) SMN1; SMN2CYP3A4CYP1A1CYP1A2CYP2E1
SCHEMBL7188354 0.85 RELA (0.42) CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8
SCHEMBL7934940 0.84 SMN1; SMN2 (0.45) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL7935034 0.84 PLAU (0.40) SMN1; SMN2MAOBAPP
SCHEMBL7928761 0.83 DHFR (0.39) SMN1; SMN2CYP3A4CYP1A1CYP1A2CYP2E1
SCHEMBL7937985 0.83 DHFR (0.41) SMN1; SMN2CYP3A4CYP1A1CYP1A2CYP2E1
SCHEMBL7928856 0.82 SMN1; SMN2 (0.51) SMN1; SMN2CYP3A4CYP1A1CYP1A2CYP2E1
SCHEMBL7190347 0.81 ESR1 (0.52) ESR1ESR2
SCHEMBL7190349 0.81 ESR1 (0.52) ESR1ESR2
SCHEMBL8500250 0.81 KDM4E (0.38) SMN1; SMN2CYP3A4CYP1A2CYP2C19ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835868-B1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods LILLY CO ELI (US) 2001-08-29 EP disclosed
US-5929090-A NOVEL COMPOUNDS FOR TREATING ESTROGEN DEPRIVATION CAUSED BY MENOPAUSE OR OVARIECTOMY; TREATING OSTEOPOROSIS, CARDIOVASCULAR DISEASES, AND ENDOMETRIOSIS ELI LILLY AND COMPANY (US) 1999-07-27 US disclosed
EP-0835868-A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods ELI LILLY AND COMPANY (US) 1998-04-15 EP disclosed